Next report date
Report period
H1 2024
EPS estimate
—
Revenue estimate
—
0.018EUR
68.27 MEUR
787.39 MEUR
1.85 B
About LUYE PHARMA GROUP LIMITED
Luye Pharma Group Ltd. is an investment holding company, which engages in the developing, producing, marketing, and selling pharmaceutical products. It operates through the following segments: Oncology Drugs, Cardiovascular System Drugs, Alimentary Tract and Metabolism Drugs, and Others. The company was founded on June 8, 1994 and is headquartered in Yantai, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange LUYE PHARMA GROUP DL-,02 stocks are traded under the ticker LUP.
LUYE PHARMA GROUP DL-,02 is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
LUP earnings for the last quarter are 0.01 EUR per share, whereas the estimation was 0.00 EUR resulting in a 35.33% surprise. The estimated earnings for the next quarter are 0.01 EUR per share. See more details about LUYE PHARMA GROUP DL-,02 earnings.
LUYE PHARMA GROUP DL-,02 revenue for the last quarter amounts to 367.05 M EUR despite the estimated figure of 376.09 M EUR. In the next quarter revenue is expected to reach 406.07 M EUR.
Yes, you can track LUYE PHARMA GROUP DL-,02 financials in yearly and quarterly reports right on TradingView.
LUP net income for the last quarter is 47.95 M EUR, while the quarter before that showed 19.84 M EUR of net income which accounts for 141.70% change. Track more LUYE PHARMA GROUP DL-,02 financial stats to get the full picture.
Like other stocks, LUP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LUYE PHARMA GROUP DL-,02 stock right from TradingView charts — choose your broker and connect to your account.
We've gathered analysts' opinions on LUYE PHARMA GROUP DL-,02 future price: according to them, LUP price has a max estimate of 0.59 EUR and a min estimate of 0.29 EUR. Read a more detailed LUYE PHARMA GROUP DL-,02 forecast: see what analysts think of LUYE PHARMA GROUP DL-,02 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LUYE PHARMA GROUP DL-,02 EBITDA is 206.31 M EUR, and current EBITDA margin is 26.37%. See more stats in LUYE PHARMA GROUP DL-,02 financial statements.